Quantitative and Ultrasensitive In-situ Immunoassay Technology for SARS-CoV-2 Detection in Saliva

Mostrar otras versiones (1)

The COVID-19 pandemic has become an immense global health crisis. However, the lack of efficient and sensitive on-site testing methods limits early detection for timely isolation and intervention. Here, we present a Quantitative and Ultrasensitive in-situ Immunoassay Technology for SARS-CoV-2 detect...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuchao, Roma, Gianluca, Liu, Fei, Lee, Luke P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814831/
https://www.ncbi.nlm.nih.gov/pubmed/33469572
http://dx.doi.org/10.21203/rs.3.rs-138025/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814831/
https://www.ncbi.nlm.nih.gov/pubmed/33469572
http://dx.doi.org/10.21203/rs.3.rs-138025/v1

Ejemplares similares